Cancer immunotherapy has emerged as a groundbreaking approach in cancer treatment, harnessing the body's immune system to recognize and destroy cancer cells. While traditional chemotherapy and radiation therapy have been widely used, they often come with significant side effects and limited efficacy. Cyclodextrins, cyclic oligosaccharides with a unique molecular structure, have shown great potential as carriers for targeted drug delivery in cancer immunotherapy. This review explores the various applications of cyclodextrins in cancer immunotherapy, highlighting their advantages, challenges, and future prospects. Cancer remains a leading cause of mortality worldwide, necessitating innovative and effective treatment strategies. Immunotherapy, which leverages the body's immune system to combat cancer, has demonstrated remarkable success in recent years. Cyclodextrins, due to their distinctive properties, have emerged as promising candidates for enhancing the efficacy and safety of cancer immunotherapy. This review discusses the current landscape of cancer immunotherapy and explores how cyclodextrins can be utilized to address the challenges associated with conventional treatment modalities.
HTML PDFShare this article
Nuclear Medicine & Radiation Therapy received 706 citations as per Google Scholar report
